Get the Stockscreener App
23.46
0.04%
-0.010
After Hours:
23.36
-0.10
-0.43%
Burning Rock Biotech Ltd Adr stock is traded at $23.46, with a volume of 13,357.
It is down -0.04% in the last 24 hours and down -18.77% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
See More
Previous Close:
$23.47
Open:
$23.75
24h Volume:
13,357
Relative Volume:
0.40
Market Cap:
$252.58M
Revenue:
$74.74M
Net Income/Loss:
$-16.85M
P/E Ratio:
-14.59
EPS:
-1.6078
Net Cash Flow:
$-4.65M
1W Performance:
+6.73%
1M Performance:
-18.77%
6M Performance:
+166.29%
1Y Performance:
+360.00%
1-Day Range:
$23.11
$23.75
1-Week Range:
$20.33
$23.81
52-Week Range:
$2.18
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
23.46 | 252.69M | 74.74M | -16.85M | -4.65M | -1.6078 |
|
TMO
Thermo Fisher Scientific Inc
|
495.72 | 185.77B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.06 | 138.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
600.52 | 47.68B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
115.42 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
297.54 | 29.39B | 3.17B | 642.63M | 516.49M | 10.77 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Biotech (NASDAQ:BNR) Trading Down 9.7%Here's What Happened - MarketBeat
Intel, Iris Energy among market cap stock movers on Friday By Investing.com - Investing.com India
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Intel and AMD among market cap stock movers on Friday - Investing.com
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Canada
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Up 34.3% in December - MarketBeat
Burning Rock Announces Results of 2025 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Announces Results of 2025 Annual General Meeting - ChartMill
Burning Rock Biotech (NASDAQ:BNR) Trading 0.1% HigherWhat's Next? - MarketBeat
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LSX:A40AE6 - TradingView
A40AE6 Stock Price and Chart — LSX:A40AE6 - TradingView
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LS:A40AE6 - TradingView
Burning Rock Stock Up 35%+ As Loss Narrows - Sahm
Wall Street analysts’ outlook for Acumen Pharmaceuticals Inc (ABOS) - setenews.com
Metals News and Commentary - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Barchart.com
Empowering Investor Success - Morningstar
BNR: Pharma R&D growth and cost controls drove higher margins and a reduced net loss in Q3 2025 - TradingView
BNR: 3Q25 saw positive cash flow, higher margins, and strong pharma R&D and overseas revenue growth - TradingView
Operating cash flow per share of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Its Stock Has Paid Off Big Time For Atlas Lithium Corporation - Setenews
Its Stock Has Paid Off Big Time For Strategy Inc - Setenews
It is Poised to be a Bull Market for HCM II Acquisition Corp (HOND) - Setenews
Burning Rock Biotech (NASDAQ:BNR) Trading 2.8% Higher – Time to Buy? - Defense World
Burning Rock Biotech (NASDAQ:BNR) Trading 2.8% HigherTime to Buy? - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
HSG HOLDING LTD Institutional Portfolio - Nasdaq
A significant driver of top-line growth: Neonode Inc (NEON) - Setenews
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - markets.businessinsider.com
Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Finviz
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
UK Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Dividend News and Commentary - Barchart.com
The United States Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - ChartMill
Saudi Arabia Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
symbol__ Stock Quote Price and Forecast - CNN
What is the current Price Target and Forecast for Burning Rock Biotech (BNR) - Zacks Investment Research
Profitably Trade Stocks at 52-Week Highs - MarketBeat
Most Volatile Stocks, What Investors Need to Know - MarketBeat
Today's Investing Ideas - Barchart.com
Interest Rates News and Commentary - Barchart.com
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Quipt Home Medical (QIPT) Short Interest & Short Float | Updated Jan 2026 - MarketBeat
Agilon Health (AGL) Short Interest & Short Float | Updated Mar 2026 $AGL - MarketBeat
Financial News Today - Barchart.com
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):